Papers
6
Total Citations
336
H-Index
6
About
Amila Siriwardana is a urological surgeon and researcher whose work has profoundly advanced the surgical and diagnostic management of prostate cancer. Specializing in robotic-assisted radical prostatectomy (RARP), oncological outcomes, and novel imaging-guided surgical techniques, Siriwardana has established himself as a leading figure in urological oncology. His landmark 2017 study documenting superior biochemical recurrence rates and quality-of-life outcomes across 2,206 consecutive robotic prostatectomy cases (75 citations) demonstrated that mastery of this complex procedure yields exceptional long-term results. A recurring theme throughout his research is the integration of prostate-specific membrane antigen (PSMA) PET imaging into clinical practice—work that has reshaped how surgeons identify and target lymph node metastases. His multicenter studies on PSMA PET-guided salvage lymphadenectomy (64 citations) and PSMA radioguided surgery (51 citations) represent pioneering contributions to intraoperative precision oncology. Siriwardana also contributed to developing and validating predictive nomograms incorporating advanced imaging, improving preoperative patient stratification globally (71 citations). His comparative quality-of-life research on focal irreversible electroporation versus RARP further highlights his commitment to patient-centered outcomes, making his body of work essential reading for surgeons and researchers navigating modern prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6